Interest Expense in USD of Babylon Holdings Ltd from 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Babylon Holdings Ltd quarterly/annual Interest Expense history and change rate from 2020 to Q1 2023.
  • Babylon Holdings Ltd Interest Expense for the quarter ending 31 Mar 2023 was $8.82M, a 47.4% increase year-over-year.
  • Babylon Holdings Ltd Interest Expense for the twelve months ending 31 Mar 2023 was $35.6M, a 98.2% increase year-over-year.
  • Babylon Holdings Ltd annual Interest Expense for 2022 was $32.7M, a 151% increase from 2021.
  • Babylon Holdings Ltd annual Interest Expense for 2021 was $13M, a 224% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Babylon Holdings Ltd Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $35.6M $8.82M +$2.84M +47.4% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $32.7M $9.31M +$336K +3.75% 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023
Q3 2022 $32.4M $8.26M +$6.57M +390% 01 Jul 2022 30 Sep 2022 10-K 16 Mar 2023
Q2 2022 $25.8M $9.19M +$7.88M +602% 01 Apr 2022 30 Jun 2022 10-K 16 Mar 2023
Q1 2022 $17.9M $5.98M +$4.9M +452% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $13M $8.97M 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 $1.68M 01 Jul 2021 30 Sep 2021 10-K 16 Mar 2023
Q2 2021 $1.31M 01 Apr 2021 30 Jun 2021 10-K 16 Mar 2023
Q1 2021 $1.08M 01 Jan 2021 31 Mar 2021 10-K 16 Mar 2023

Babylon Holdings Ltd Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $32.7M +$19.7M +151% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023
2021 $13M +$9.02M +224% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 $4.03M 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.